Research programme: cancer therapeutics - Gene Network Sciences/University of Connecticut

Drug Profile

Research programme: cancer therapeutics - Gene Network Sciences/University of Connecticut

Latest Information Update: 13 Apr 2011

Price : $50

At a glance

  • Originator Gene Network Sciences; University of Connecticut
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Cancer; Ovarian cancer

Most Recent Events

  • 03 Jun 2009 Early research in Cancer in USA (unspecified route)
  • 03 Jun 2009 Early research in Ovarian cancer in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top